Treace Medical Concepts TMCI Cash Flow Statement (2020-2026)

NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Treace Medical Concepts Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Treace Medical Concepts reported cash from operations of -$4.70M and free cash flow of -$6.90M for the quarter ended Jun 2026, down 54.0% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.42M-6.62M-9.04M-12.75M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.62M-16.05M-17.52M-16.38M-6.75M-18.24M-16.07M
Share-based CompensationStock Comp.
8.84M1.29M1.41M1.96M2.27M2.69M3.60M5.19M5.88M7.41M6.74M7.90M8.55M8.69M9.58M8.00M7.55M8.03M6.46M
Asset Writedowns and ImpairmentWritedown
-0.04M0.03M-0.23M-0.01M0.62M0.04M0.04M0.00M0.35M0.16M2.05M0.17M0.57M0.50M0.08M-0.07M
Cash from OperationsCash from Ops.
-9.24M-3.75M-7.24M-10.57M-7.49M-5.35M-17.26M-8.34M-9.51M0.53M-7.22M-13.90M-11.84M-4.21M4.20M-3.05M-9.09M-8.03M7.24M-4.70M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.13M0.30M0.37M0.37M0.38M0.34M0.35M0.23M0.23M0.08M0.04M0.01M0.00M-0.01M-0.01M
Amortization of Deferred ChargesAmort. Deferred Charges
0.04M0.04M0.04M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.26M0.24M
Depreciation & Amortization (CF)Dep. & Amort.
0.20M0.28M0.33M0.40M0.40M0.92M0.92M1.10M1.56M1.77M1.91M2.12M2.16M2.24M2.46M2.58M2.78M2.81M0.90M1.89M
Change in Working Capital
Change in ReceivablesChange Receivables
1.76M6.97M-2.54M0.43M2.05M11.10M-3.79M1.91M-2.23M13.42M-7.82M-2.48M-1.21M17.19M-9.29M-0.70M2.56M9.52M-11.69M-1.50M
Change in InventoryChange Inventory
2.80M0.03M0.55M1.86M3.62M2.74M3.19M3.52M3.21M-0.07M6.62M5.42M2.33M-4.36M-1.31M4.46M-0.97M-5.39M0.34M3.18M
Change in Account PayablesChange Payables
-0.48M1.61M-0.61M-0.35M4.78M0.79M-3.59M3.07M0.53M3.15M9.31M-3.08M0.58M-8.13M2.70M6.74M-3.86M-9.38M6.81M2.52M
Change in Accured ExpensesChange Accured Exp.
1.34M5.87M-2.62M5.01M0.72M4.01M-4.08M0.94M1.18M9.48M-6.92M0.97M-6.81M4.85M-6.17M0.86M2.12M0.78M-3.13M2.75M
Other Working Capital ChangesOther WC Changes
-0.03M-0.01M-0.00M-0.11M-0.02M0.13M-0.10M-0.06M-0.04M0.06M-0.23M-0.04M
Investing Activities
Capital ExpendituresCapex
0.94M0.90M1.48M5.17M5.86M2.33M1.48M4.23M3.50M2.25M3.93M1.73M2.86M3.07M3.54M4.77M2.81M2.40M3.06M2.20M
Change in Acquisitions & DivestmentsChange Acquisitions
1.73M20.55M35.22M27.22M37.05M36.40M24.16M32.80M25.18M16.74M16.67M16.18M17.75M11.32M11.87M
Cash from Investing ActivitiesCash from Investing
-0.94M-0.90M-1.48M-5.17M-5.86M-64.01M-80.48M-10.42M4.60M5.01M3.76M22.43M5.76M3.42M-1.89M-3.26M8.74M9.67M-7.82M7.07M
Financing Activities
Other financing activitiesOther financing
1.37M0.17M0.35M0.30M107.53M0.05M0.31M0.01M0.06M0.12M0.12M0.24M0.07M0.09M0.01M
Cash from Financing ActivitiesCash from Financing
0.04M1.03M1.37M18.78M0.35M0.30M107.88M1.18M0.16M0.17M-0.18M0.31M0.01M0.03M-0.28M0.99M-0.01M1.38M-0.59M0.70M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.42M0.96M0.02M0.73M0.10M0.62M0.33M0.62M0.65M
Additional items
Change in Cash
-10.16M-3.63M-7.35M3.05M-12.99M-69.07M10.14M-17.58M-4.76M5.70M-3.65M8.85M-6.07M-0.76M2.02M-5.32M-0.37M3.02M-1.16M3.07M
Free Cash FlowFCF
-10.18M-4.65M-8.72M-15.73M-13.35M-7.68M-18.74M-12.57M-13.01M-1.72M-11.15M-15.63M-14.71M-7.28M0.66M-7.82M-11.90M-10.42M4.18M-6.90M
Net Cash FlowNCF
-10.14M-3.63M-7.35M3.05M-13.00M-69.06M10.14M-17.58M-4.76M5.70M-3.65M8.85M-6.07M-0.76M2.02M-5.32M-0.37M3.02M-1.16M3.07M